CollPlant宣布完成 370万美元的私募配售-动脉网

COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT

CISION 等信源发布 2026-10-09 21:00



可切换为仅中文







Transaction Led Primarily by Existing Investors to Accelerate LightSolver's Laser-Based Supercomputing Development

由现有投资者主导的交易，旨在加速 LightSolver 基于激光的超级计算开发

REHOVOT, Israel

以色列雷霍沃特

，

Oct. 9, 2026

2026年10月9日

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq:

/美通社/ -- CollPlant Biotechnologies（纳斯达克：

CLGN

), an innovative technology company operating at the intersection of deep-tech photonic computing and biotechnology today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 989,301 of the Company's ordinary shares (or ordinary share equivalents in lieu thereof) and unregistered warrants to purchase up to 1,483,952 ordinary shares in a private placement at a combined purchase price of $3.74 per ordinary share and accompanying warrants (or $3.7399 per ordinary share equivalent and accompanying warrants).

），一家在深度科技光子计算与生物技术交叉领域运营的创新科技公司，今日宣布已签订最终协议，以私募方式发行并出售总计989,301股公司普通股（或替代的普通股等价物）以及未注册的认股权证，该等认股权证最多可购买1,483,952股普通股，每股普通股及附随认股权证的合并购买价格为3.74美元（或每股普通股等价物及附随认股权证的价格为3.7399美元）。

The private placement, which is comprised primarily of the Company's existing investors, reflects confidence in CollPlant's expanded strategic vision and its execution capabilities in deep-tech photonic computing. The warrants will have an exercise price of $3.74 per share, will be exercisable immediately upon issuance and will expire five years after the effective date of a registration statement registering the shares issuable upon exercise of the warrants.

本次私募配售主要面向公司现有投资者，体现了市场对CollPlant拓展后的战略愿景及其在深科技光子计算领域执行能力的信心。认股权证的行权价格为每股3.74美元，自发行之日起即可行权，并在登记可因行使认股权证而发行股份的注册声明生效之日后五年到期。

The private placement is expected to close on or about October 14, 2026, subject to the satisfaction of customary closing conditions..

预计此次私募配售将于2026年10月14日或前后完成，但须满足惯例交割条件。

H.C. Wainwright & Co. and Rodman & Renshaw LLC are acting as the exclusive joint placement agents for the private placement.

H.C. Wainwright & Co. 和 Rodman & Renshaw LLC 担任本次私募发行的独家联合配售代理。

The gross proceeds from the private placement, before deducting the placement agent's fees and other related expenses payable by the Company, are expected to be approximately $3.7 million. CollPlant intends to use the net proceeds from this offering primarily to accelerate the research and development programs of its subsidiary, LightSolver, focusing on the advancement and scalability of its proprietary laser-based supercomputing architecture and Laser Processing Unit (LPU™) technology as well as general corporate purposes including working capital..

在扣除公司应支付的配售代理费及其他相关费用之前，此次私募发行的总收益预计约为370万美元。CollPlant打算将此次发行所得的净收益主要用于加速其子公司LightSolver的研发计划，重点推进其专有的基于激光的超级计算架构和激光处理单元（LPU™）技术的进步与可扩展性，以及用于包括营运资金在内的一般企业用途。

The offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933, as amended (the 'Securities Act'), and/or Regulation D promulgated thereunder, and applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or applicable state securities laws.

上述证券的发售和销售依据的是经修订的《1933年证券法》（以下简称“《证券法》”）第4(a)(2)条以及据此颁布的D条例和适用的州证券法所规定的注册豁免。这些证券过去未曾且初始也不会根据《证券法》或适用的州证券法进行注册。

Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to the terms of the securities purchase agreement entered into with the investors, the Company has agreed to file a registration statement with the U.S.

因此，除非依据生效的注册声明或适用《证券法》及相应州证券法律规定的注册要求豁免，否则不得在美国要约或出售该等证券。根据与投资者签订的证券购买协议的条款，公司已同意向美国提交一份注册声明。

Securities and Exchange Commission covering the resale of the ordinary shares and ordinary shares underlying the warrants sold in the private placement..

美国证券交易委员会，涵盖私募配售中出售的普通股及权证所对应的普通股的转售事宜。

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction..

本新闻稿不构成出售要约或购买要约的征求，在任何司法管辖区，若根据该司法管辖区的证券法在注册或资格认定之前进行此类要约、征求或销售属违法行为，则不得在该司法管辖区销售这些证券。

About CollPlant

关于 CollPlant

CollPlant (Nasdaq:

CollPlant（纳斯达克：

CLGN

) is an innovative technology company operating at the intersection of deep-tech photonic computing and advanced biotechnology. Through its subsidiary LightSolver, CollPlant is advancing the development of proprietary all-optical laser based computing architectures designed to resolve the world's most demanding computational bottlenecks across artificial intelligence, aerospace, financial engineering, and high-performance computing.

）是一家在深度技术光子计算与先进生物技术交叉领域运营的创新型科技公司。通过其子公司 LightSolver，CollPlant 正在推进专有的全光学激光计算架构的开发，旨在解决人工智能、航空航天、金融工程和高性能计算领域中最具挑战性的计算瓶颈。

Concurrently, CollPlant remains a leader in regenerative medicine, pioneering plant-derived recombinant human collagen technologies for 3D bioprinting of tissues and organs and medical aesthetics..

与此同时，CollPlant 在再生医学领域保持领先地位，率先开发用于组织和器官 3D 生物打印以及医学美容的植物源重组人胶原蛋白技术。

For more information about CollPlant, visit

欲了解更多关于 CollPlant 的信息，请访问

http://www.collplant.com

。

Forward-Looking Statements

前瞻性陈述

This press release may include forward-looking statements. Forward-looking statements include, but are not limited to, statements relating to the completion of the private placement, the satisfaction of customary closing conditions related to the private placement and the intended use of proceeds from the private placement as well as statements, other than historical facts, that address activities, events or developments that CollPlant intends, expects, projects, believes or anticipates will or may occur in the future.

本新闻稿可能包含前瞻性陈述。前瞻性陈述包括但不限于，与完成私募配售、满足与私募配售相关的惯例交割条件以及私募配售所得款项的预期用途有关的陈述，以及除历史事实外，涉及CollPlant意图、预期、预测、相信或预计将来会或可能发生的活动、事件或发展的陈述。

These statements are often characterized by terminology such as 'believes,' 'hopes,' 'may,' 'anticipates,' 'should,' 'intends,' 'plans,' 'will,' 'expects,' 'estimates,' 'projects,' 'positioned,' 'strategy' and similar expressions and are based on assumptions and assessments made in light of management's experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate.

这些陈述通常以“相信”、“希望”、“可能”、“预期”、“应当”、“打算”、“计划”、“将”、“预计”、“估计”、“预测”、“定位”、“战略”等术语及类似表述为特征，并基于管理层结合其经验以及对历史趋势、当前状况、预期未来发展和其他被认为适当因素的看法而作出的假设和评估。

Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Many factors could cause CollPlant's actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the following: the risk that the anticipated benefits of the LightSolver transaction are not realized, or are not realized within the expected timeframe; risks associated with integrating LightSolver's business, operations and personnel; LightSolver's ability to achieve anticipated technological and commercial milestones; uncertainties regarding market acceptance and adoption of LightSolver's technology; the abilit.

前瞻性陈述并非对未来表现的保证，并受制于可能导致实际结果与此类陈述中明示或暗示的结果存在重大差异的风险和不确定性。许多因素可能导致 CollPlant 的实际活动或结果与前瞻性陈述中预期的活动和结果存在重大差异，包括但不限于以下因素：未能实现或未在预期时间框架内实现 LightSolver 交易预期效益的风险；与整合 LightSolver 的业务、运营和人员相关的风险；LightSolver 实现预期技术和商业里程碑的能力；关于市场接受和采用 LightSolver 技术的不确定性；能力。

Contacts

联系人

CollPlant:

CollPlant：

Eran Rotem

埃兰·罗特姆

Deputy CEO & CFO

副总裁兼首席财务官

Tel: + 972-73-2325600

电话：+972-73-2325600

Email:

电子邮件：